Indication
Detrusor Muscle Hyperactivity
1 clinical trial
2 products
Product
Botulinum toxin type AClinical trial
A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.Status: Completed, Estimated PCD: 2013-03-01
Product
Placebo